The immune system in atherosclerosis

Area of Science:

• Immunology
• Cardiovascular Medicine
• Pathology

Background:

• Cardiovascular disease is a major global health issue, primarily driven by atherosclerosis.
• Atherosclerosis is characterized by chronic inflammation in blood vessels, involving immune cells and cholesterol accumulation.
• Immune system components, including innate and adaptive responses, play a significant role in atherosclerosis development.

Purpose of the Study:

• To explore the intricate involvement of the immune system in the pathogenesis of atherosclerosis.
• To investigate how immune responses, triggered by factors like low-density lipoprotein, contribute to disease progression.
• To lay the groundwork for novel immunomodulatory therapies for atherosclerosis.

Main Methods:

• Analysis of immune cell infiltration in atherosclerotic lesions.
• Investigation of gene expression related to costimulatory factors and cytokines in disease models.
• Studies on the impact of manipulating regulatory immunity on atherosclerosis.
• Examination of low-density lipoprotein's role in triggering immune responses.

Main Results:

• Targeted gene deletion of specific immune factors reduced atherosclerosis in mouse models.
• Interference with regulatory immunity exacerbated atherosclerosis.
• Both innate and adaptive immune responses were identified as integral to the disease process.
• Low-density lipoprotein components were shown to activate inflammatory pathways and immune cells.

Conclusions:

• The immune system is a critical determinant in the development and progression of atherosclerosis.
• Modulating immune responses holds promise for future therapeutic strategies against cardiovascular disease.
• Further research into immune system involvement can lead to innovative treatments for atherosclerosis.